Biotech

All Articles

Amgen records first stage 3 win for $400M eczema medicine

.Amgen has actually shared (PDF) the 1st stage 3 records on its own $400 million chronic eczema drug...

Biogen, UCB document stage 3 lupus gain after neglecting earlier test

.Biogen and also UCB's bank on advancing into period 3 on the back of a failed research study aims t...

Aptadir wishes brand new RNA inhibitors can easily reverse challenging cancers cells

.Italian biotech Aptadir Rehabs has launched along with the guarantee that its own pipeline of precl...

Wave surfs DMD success to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has actually fulfilled its own objective in a Duchenne muscular dystrophy ...

Sanofi picks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fol...

Achilles droplets tissue treatment program, braces for discharges after missing out on 'industrial feasibility' objectives

.Achilles Therapeutics has destroyed its own tactic. The English biotech is actually stopping work o...

Aligos proclaims phase 2 MASH gain, reducing liver body fat as much as 46%

.Aligos Therapeutics is actually declaring a midstage gain in metabolic-dysfunction connected steato...

Basilea scores $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job developing new antifungals has actually received a considerable boost c...

Capricor offers Europe rights to late-stage DMD treatment for $35M

.Having presently gathered up the USA liberties to Capricor Therapies' late-stage Duchenne muscle dy...

FDA fragments adcomm for Applied's rare health condition medicine

.After pushing back the choice date for Applied Therapeutics' metabolic problem drug govorestat, the...